Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls

Table 2

Characteristics of study group (PCOS group).

	PCOS + NAFLD	PCOS − NAFLD	Whole group (PCOS)
GOT (U/L)	24.06 ± 11.22	22.13 ± 8.36	23.24 ± 10.13
GPT (U/L)	27.17 ± 18.09	20.26 ± 14.35	24.25 ± 16.92
GGTP (U/L)	30.37 ± 21.83	21.74 ± 13.89	26.66 ± 19.27
Bilirubin (mg/dL)	0.677 ± 0.364	0.694 ± 0.430	0.684 ± 0.391
Triglycerides (mg/dL)	120.00 ± 70.18	94.60 ± 58.52	109.30 ± 66.53
Total cholesterol (mg/dL)	191.00 ± 36.22	185.30 ± 37.39	188.60 ± 36.72
LDL cholesterol (mg/dL)	113.30 ± 32.27	104.10 ± 28.93	109.50 ± 31.17
HDL cholesterol (mg/dL)	53.63 ± 16.3	63.68 ± 19.63	57.88 ± 18.42
Mean glucose level (mg/L)	113.40 ± 23.54	102.40 ± 24.97	108.70 ± 24.7
Mean insulin level (𝜇IU/mL)	60.46 ± 43.89	37.40 ± 20.56	50.59 ± 37.52
Testosterone (ng/mL)	0.653 ± 0.295	0.57 ± 0.322	0.619 ± 0.308
SHBG (mmol/L)	34.17 ± 19.63	46.06 ± 29.42	39.18 ± 24.87
FAI value	9.394 ± 8.484	6.10 ± 5.151	8.008 ± 7.434

Data are presented as mean ± SD.